|
Volumn 558, Issue 7711, 2018, Pages 497-498
|
Genetically modified bacteria enlisted in fight against disease news
a
a
NONE
|
Author keywords
Gene therapy; Microbiology; Microbiome
|
Indexed keywords
AMINO ACID;
DNA;
PHENYLALANINE;
BACTERIAL DISEASE;
BACTERIUM;
BIODEGRADATION;
COLIFORM BACTERIUM;
DISEASE;
DISEASE TREATMENT;
ENZYME;
ENZYME ACTIVITY;
GENETICALLY MODIFIED ORGANISM;
MICROBIOLOGY;
PROTEIN;
ARTICLE;
BACTERIAL GENE;
BACTERIAL MICROBIOME;
BACTERIAL STRAIN;
BACTERIUM;
CLINICAL TRIAL (TOPIC);
DISEASES;
ENZYME DEGRADATION;
ESCHERICHIA COLI;
FOOD INTAKE;
GENE THERAPY;
GENETIC RISK;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
IMMUNOCOMPETENT CELL;
LONG TERM CARE;
NONHUMAN;
PHENYLKETONURIA;
PRIORITY JOURNAL;
RISK FACTOR;
TRANSGENIC MICROORGANISM;
UNITED STATES;
ANIMAL;
BACTEROIDES;
BIOLOGICAL THERAPY;
COLITIS;
ETHICS;
GENETICS;
HORIZONTAL GENE TRANSFER;
LACTOBACILLUS;
LACTOCOCCUS LACTIS;
METABOLISM;
MICROBIOLOGY;
MOUSE;
PROCEDURES;
ANIMALS;
BACTERIA;
BACTEROIDES;
BIOLOGICAL THERAPY;
CLINICAL TRIALS AS TOPIC;
COLITIS;
ESCHERICHIA COLI;
GENE TRANSFER, HORIZONTAL;
HIV INFECTIONS;
HUMANS;
LACTOBACILLUS;
LACTOCOCCUS LACTIS;
MICE;
PHENYLALANINE;
PHENYLKETONURIAS;
|
EID: 85049234817
PISSN: 00280836
EISSN: 14764687
Source Type: Journal
DOI: 10.1038/d41586-018-05476-4 Document Type: Article |
Times cited : (12)
|
References (3)
|